THE EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF A SYNDROME OF KASABACH-MERRITT AT CHILDREN ON THE FIRST YEAR OF LIFE

P. V Tokarev; Rinat Akhmedullovich Saleev; A. V Shulaev; L. V Plaksina; N. T Safin

doi:10.18821/1728-2802-2019-23-2-69-71

Russian Journal of Dentistry ›› 2019, Vol. 23 ›› Issue (2) : 69 -71. DOI: 10.18821/1728-2802-2019-23-2-69-71

Articles

research-article

THE EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF A SYNDROME OF KASABACH-MERRITT AT CHILDREN ON THE FIRST YEAR OF LIFE

Author information +

History +

PDF

Abstract

A solitary hemangioma with thrombocytopenia and general coagulation disorders is rather rare disease. There are definite difficulties in diagnostic and treatment of this disease. In this article we describe two clinical cases of Kasabach-Merritt syndrome diagnostic and treatment.

Keywords

Kasabach-Merritt syndrome / extensive hemangioma / thrombocytopenia / coagulopathy

Cite this article

Download citation ▾

P. V Tokarev, Rinat Akhmedullovich Saleev, A. V Shulaev, L. V Plaksina, N. T Safin. THE EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF A SYNDROME OF KASABACH-MERRITT AT CHILDREN ON THE FIRST YEAR OF LIFE. Russian Journal of Dentistry, 2019, 23(2): 69-71 DOI:10.18821/1728-2802-2019-23-2-69-71

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Поляев Ю.А., Постников С.С., Мыльников А.А., Гарбузов Р.В., Нарбутов А.Г., Шимановский Н.Л. Новые возможности в лечении инфантильных гемангиом с помощью пропранолола. Международный медицинский журнал. 2012; 2: 94-103.

[2]	Leaute-Labreze C., Prey S., Ezzedine K. Infantile haemangioma: Part II. Risks, complications and treatment. J. Eur. Acad. Dermato.l Venerol. 2011; 25: 1254 - 60.

[3]	Oak S.N., Viswanath K. Management of hemangioma in children. Indian J. Dermatol. Venerol. Leprol. 2006; 18 (72): 1-4.

[4]	Zvulunov A., McCuaig C., Frieden I.J., et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr. Dermatol. 2011; 28 (2): 94-8.

[5]	Leaute-Labreze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 2008; 358 (24): 2649 - 51.

[6]	Kilkline C., Frieden I.J. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr. Dermatol. 2008; 25: 168 - 73.

[7]	Buckmiller L.M., Munsun. P.D., Dyamenahalli U., et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010; 120: 676 - 81.

[8]	Stroch C. H., Hoeger P.H. Propranolol for infantile hemangiomas: insights into the molecular mechanisms of actions. Br. J. Dermatol. 2010; 163(2): 269 -74.

[9]	Schiestl C., Neuhaus K. , Zoller S. et al. Efficacy and safety of propranolol at first - line treatment for infantile hemangiomas. Eur. J. Pediatr. 2011; 170 (4): 493 - 501.

[10]	Leonardi-Bee J., Batta K., O’Brien C., Bath-Hextall F.J. Intervenous for infantile hemangiomas (strawberry birth marks) of the skin. Cochrane Database Syst Rev. 2011; (5): CD006545.